Compound class:
Synthetic organic
Comment: FNDR-20123 is the most potent antimalarial compound identified from a HDAC inhibitor library screening study [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
FNDR-20123 is a potent inhibitor of both PfHDAC1 (31 nM) and human HDAC (3 nM). The interaction table below provides data from whole cell assays and gives the antiparasite activity of FNDR-20123 against both the sexual and asexual blood stages of the Plasmodium lifecycle. The evaluation of asexual blood stage activity utilized a panel of culture-adapted P. falciparum strains, with FNDR-20123 demonstrating no evidence of reduced potency against drug resistant strains. |
Whole organism assay data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click on species/strain names for details | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|